Literature DB >> 17641681

Autologous translocation of the choroid and RPE in age-related macular degeneration: 1-year follow-up in 30 patients and recommendations for patient selection.

F M A Heussen1, N F Fawzy, S Joeres, A Lux, K Maaijwee, J Cv Meurs, B Kirchhof, A M Joussen.   

Abstract

AIM: To evaluate the long-term (1 year) functional and anatomical outcome of autologous translocation of peripheral choroid and retinal pigment epithelium (RPE) in 30 patients with age-related macular degeneration (AMD).
METHODS: After the extraction of the neovascular complex, an autologous peripheral full-thickness graft of RPE and choroid was positioned under the macula. Functional tests included ETDRS vision, reading (Radner test), and microperimetry (scanning laser ophthalmoscope). Fluorescein, indocyanine green angiography, and autofluorescence were monitored.
RESULTS: Preoperative visual acuity ranged from 20/40 to 20/800 (0.3-1.6 log MAR). Vision ranged from 20/25 to LP (0.1-2.1 log MAR) 1 year after surgery, with stabilization in six eyes, an increase in five eyes, and a decrease in 19 eyes. Deterioration mostly occurred within the first 3 months after surgery. In patients who demonstrated vascularization of the graft after 3 months, this persisted up to 12 months as did fixation when initially stable. Autofluorescence decreased significantly from 6 to 12 months postoperatively. Eleven cases showed a recurrence of choroidal neovascularization (CNV) within this period.
CONCLUSION: Patch translocation results in a viable graft. There is no evidence of graft failure within a 1-year follow-up. Nevertheless, there is risk for late CNV formation originating from the edges of the excision side of the CNV and growing peripheral to the graft.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17641681     DOI: 10.1038/sj.eye.6702823

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  14 in total

Review 1.  Cell replacement and visual restoration by retinal sheet transplants.

Authors:  Magdalene J Seiler; Robert B Aramant
Journal:  Prog Retin Eye Res       Date:  2012-07-05       Impact factor: 21.198

2.  Enhancing RPE Cell-Based Therapy Outcomes for AMD: The Role of Bruch's Membrane.

Authors:  Janosch P Heller; Keith R Martin
Journal:  Transl Vis Sci Technol       Date:  2014-07-03       Impact factor: 3.283

Review 3.  [Suprachoroidal hydrogel buckling].

Authors:  K Boden; K Januschowski; P Szurman
Journal:  Ophthalmologe       Date:  2018-11       Impact factor: 1.059

4.  Human induced pluripotent stem-derived retinal pigment epithelium (RPE) cells exhibit ion transport, membrane potential, polarized vascular endothelial growth factor secretion, and gene expression pattern similar to native RPE.

Authors:  Maria Kokkinaki; Niaz Sahibzada; Nady Golestaneh
Journal:  Stem Cells       Date:  2011-05       Impact factor: 6.277

5.  Cost-effectiveness of autologous retinal pigment epithelium and choroid translocation in neovascular AMD.

Authors:  Aljoscha S Neubauer; Sandra Liakopoulos; Jan C van Meurs; Bernd Kirchhof
Journal:  Int J Ophthalmol       Date:  2010-09-18       Impact factor: 1.779

Review 6.  Cell-based therapeutic strategies for replacement and preservation in retinal degenerative diseases.

Authors:  Melissa K Jones; Bin Lu; Sergey Girman; Shaomei Wang
Journal:  Prog Retin Eye Res       Date:  2017-01-19       Impact factor: 21.198

7.  COMBINED AUTOLOGOUS TRANSPLANTATION OF NEUROSENSORY RETINA, RETINAL PIGMENT EPITHELIUM, AND CHOROID FREE GRAFTS.

Authors:  Barbara Parolini; Dilraj S Grewal; Sajish J Pinackatt; Andrea Baldi; Attilio Di Salvatore; Gianluca Besozzi; Alessandro Finzi; Daniele Cardillo; Tamer H Mahmoud
Journal:  Retina       Date:  2018-09       Impact factor: 4.256

8.  Age-related macular degeneration: current treatments.

Authors:  Jean Pierre Hubschman; Shantan Reddy; Steven D Schwartz
Journal:  Clin Ophthalmol       Date:  2009-06-02

9.  Autologous translocation of choroid and retinal pigment epithelium in geographic atrophy: long-term functional and anatomical outcome.

Authors:  Albert Caramoy; Sandra Liakopoulos; Erica Menrath; Bernd Kirchhof
Journal:  Br J Ophthalmol       Date:  2009-08-18       Impact factor: 4.638

10.  Choice of Cell Source in Cell-Based Therapies for Retinal Damage due to Age-Related Macular Degeneration: A Review.

Authors:  Sudhakar John; Sundaram Natarajan; Periyasamy Parikumar; Mahesh Shanmugam P; Rajappa Senthilkumar; David William Green; Samuel J K Abraham
Journal:  J Ophthalmol       Date:  2013-04-22       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.